Back to
VANGUARD GROUP INC
ALNY6 quarters
Position history for
VANGUARD GROUP INC's holdings in ALNYLAM PHARMACEUTICALS INC
As of its last 13F, for Q4 2025, Vanguard Group held 13,553,932 shares of ALNY (Alnylam Pharmaceuticals), worth $5.4B. It reduced the position by 11,520 shares (-0.1%) from Q3 2025. Vanguard Group held ALNY from Q3 2024 to Q4 2025, across 6 quarterly 13F filings. ALNY was 0.1% of Vanguard Group's reported 13F portfolio.
Current Value
$5.4B
Current Shares
13.6M
Total Value Change
+$1.9B
Total Shares Change
+918,836
Quarter-by-Quarter History
Other major holders of ALNY: FMR LLC, Capital World Investors